Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 23.08%. A quarter ago, it was expected that this maker of products used in the treatment of kidney disease and anemia would post a loss of $0.12 per share when it actually produced a loss of $0.12, deliverin…

Click here to view the original article.